New Drugs, Uncounted COVID Deaths & Endo Awareness
Cleveland News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Generic versions of semaglutide, a popular diabetes and obesity treatment, are set to hit markets in several countries, potentially reducing prices to a fraction of US levels. Meanwhile, Eli Lillys new oral pill retatrutide showed promising results in its first big trial, with patients losing nearly seventeen percent of their body weight. Another oral drug, aleniglipron, helped people shed an average of nearly forty pounds in mid-stage trials. In other news, a new study found up to one hundred fifty-five thousand covid deaths in twenty twenty and twenty twenty-one went uncounted, disproportionately affecting Hispanic folks and people of color. Lastly, endometriosis awareness month highlights a condition affecting millions of US women, often taking seven to ten years to diagnose.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/ae3fe9dfd8020f96